Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Canonichesi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Cellular Neuroscience|February 17, 2025
Enhancing sleep quality in synucleinopathies through physical exerciseJacopo Canonichesi, Laura Bellingacci, Francesco Rivelli, et al.
Neural Regeneration Research|July 14, 2023
Cytokines, synaptic plasticity and network dynamics: a matter of balanceLaura Bellingacci, Jacopo Canonichesi, Andrea Mancini, et al.
Clinical and Translational Medicine|October 31, 2025
Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genesLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Miriam Sciaccaluga, et al.
International Journal of Molecular Sciences|February 10, 2024
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation DeficitsLaura Bellingacci, Jacopo Canonichesi, Miriam Sciaccaluga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
Gene therapy for Lafora disease in the Epm2a<sup>-/-</sup> mouse modelLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Daniel F Burgos, et al.
NPJ Parkinson'S Disease|July 29, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptomsLaura Bellingacci, Miriam Sciaccaluga, Alfredo Megaro, et al.
Multiple Sclerosis and Related Disorders|February 21, 2025
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosisGiulia Menculini, Silvia Sperandei, Lorenzo Gaetani, et al.
Epilepsia|December 18, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora diseaseCinzia Costa, Laura Bellingacci, Jacopo Canonichesi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular Neuroscience|February 17, 2025
Enhancing sleep quality in synucleinopathies through physical exerciseJacopo Canonichesi, Laura Bellingacci, Francesco Rivelli, et al.
Neural Regeneration Research|July 14, 2023
Cytokines, synaptic plasticity and network dynamics: a matter of balanceLaura Bellingacci, Jacopo Canonichesi, Andrea Mancini, et al.
Clinical and Translational Medicine|October 31, 2025
Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genesLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Miriam Sciaccaluga, et al.
International Journal of Molecular Sciences|February 10, 2024
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation DeficitsLaura Bellingacci, Jacopo Canonichesi, Miriam Sciaccaluga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
Gene therapy for Lafora disease in the Epm2a<sup>-/-</sup> mouse modelLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Daniel F Burgos, et al.
NPJ Parkinson'S Disease|July 29, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptomsLaura Bellingacci, Miriam Sciaccaluga, Alfredo Megaro, et al.
Multiple Sclerosis and Related Disorders|February 21, 2025
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosisGiulia Menculini, Silvia Sperandei, Lorenzo Gaetani, et al.
Epilepsia|December 18, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora diseaseCinzia Costa, Laura Bellingacci, Jacopo Canonichesi, et al.
Pageof 1